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Microsomal membranes from the slow-growing Morris hepatoma 9618A catalyze, in the presence of t-butyl 
hydroperoxide, lower rates of lipid peroxidation than rat liver microsomes. The cytochrome P-450 content 
of hepatoma microsomes is about 40% that of the liver. SKF 525-A, an inhibitor of mixed-function oxidase, 
produces in hepatoma microsomes a P-450 type I binding spectrum similar to that of hepatic microsomes. 
The concentration of the inhibitor required for half-maximal spectral change is about 2 PM in both micro- 
some types. SKF 525-A or ethylmorphine inhibit lipid peroxidation of normal and tumor microsomes to 
the same extent (about 60%). Treatment of the tumor-bearing rats with 3-methylcholanthrene increases the 
hepatoma cytochrome P-450 to values comparable to those of control membranes, although the hemopro- 
tein has a peak in the CO-reduced difference absorption spectrum at 448 nm. The cytochrome P-448 induc- 
tion is accompanied by an almost complete restoration of the hydroperoxide-dependent lipid peroxidation. 
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1. INTRODUCTION 
Neoplastic transformation of the liver is 
characterized by a decrease in the vulnerability of 
the intracellular and plasma membranes to perox- 
idative agents [I]. The most remarkable changes 
are observable in membranes isolated from fast- 
growing hepatomas, where the major limiting fac- 
tor appears to be the lipid substrate availability 
(low phospholipid content and degree of fatty acid 
unsaturation). Evidence has been provided, 
however, that microsomes from the slow-growing 
hepatoma 9618A, although they have a normal 
lipid composition, may fail to propagate lipid 
peroxidation initiated by 0; radicals [2] or even to 
be resistant to the entire process (initiation and 
propagation reactions) when it is promoted by 
* To whom correspondence should be addressed 
organic hydroperoxides (ROOH) [3]. In both cir- 
cumstances cytochrome P-450 deficiency, rather 
than an increase in the protective effect of mem- 
brane antioxidants, seems to be the rate-limiting 
step. This is in accordance with the proposed im- 
plication of the hemoprotein in the oxidation of 
lipid hydroperoxides (LOOH), formed during the 
initiation step, to propagating radicals [4] as well 
as in the oxidation of ROOH to initiating radicals 
[51. 
In the present study we have reexamined the 
lipid peroxidation of hepatoma 96 18A microsomes 
by using a ROOH-dependent system, with the aim 
of verifying the previous conclusions on the in- 
volvement of cytochrome P-450 as ROOH and 
LOOH oxidase. For this purpose, the effect on t- 
butyl hydroperoxide (t-BuOOH)-induced perox- 
idation of mixed-function oxidase inhibitors or 
substrates has been tested, comparatively, in rat 
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liver and tumor microsomes. Furthermore, ex- 
periments have been performed in order to 
reconstitute the normal level of cytochrome P-450 
in the hepatoma membranes. Such a condition was 
afforded by the use of 3-methylcholanthrene 
(MC), whose administration to the tumor-bearing 
rats induces an elevation of the hemoprotein in the 
form of cytochrome P-448. Membranes from MC- 
induced hepatomas hould thus be able to catalyze 
rates of hydroperoxide-dependent lipid peroxida- 
tion similar to those of rat liver membranes. 
2. MATERIALS AND METHODS 
Morris hepatoma 9618A was propagated by sub- 
cutaneous transplantation into both hind legs of 
inbred rats of the Buffalo strain. Details concern- 
ing the growth and isolation of the tumor are 
reported elsewhere [6,7]. Tumor-bearing rats were 
treated intraperitoneally with 3-methylcholan- 
threne (30 mg/kg body wt) in corn oil for 3 days 
[8] or orally with sodium phenobarbital (1 mg/ml 
drinking water) for 5 days [9]. The animals were 
killed 24 h after treatment. Normal male rats 
(150-200 g) of the same strain were used as con- 
trols. Rat liver and hepatoma microsomes were 
isolated in 0.25 M sucrose, 0.5 mM EGTA, 5 mM 
Hepes (pH 7.4) as in [lo]. The fractions were wash- 
ed once by centrifugation in 0.15 M KCl, 50 mM 
Tris-HCl (pH 7.5) and suspended in the same 
medium. Proteins were estimated by the biuret 
method [II]. 
Lipid peroxidation was performed at 37°C in 
capped flasks containing 0.2-0.5 mg protein/ml, 
0.11 mM EDTA, 0.15 M KCl, 50 mM Tris-HCl 
(pH 7.5). The reaction was started by the addition 
of 0.25 or 2 mM t-BuOOH and was allowed to run 
for the time indicated in a Dubnoff metabolic 
shaker. Lipid peroxidation was measured as 
malondialdehyde (MDA) formation, by the 
thiobarbituric acid assay at 535 nm [12]. The con- 
tent of cytochrome P-450 or P-448 was calculated 
from CO-reduced difference absorption spectra, 
performed in a dual-wavelength/split-beam 
Aminco-Chance spectrophotometer, using an ex- 
tinction coefficient of 91 mM_’ *cm-’ [13]. 
Changes in absorbance induced by the addition of 
increasing concentrations of SKF 525-A to aerobic 
microsomes (2 mg protein/ml) were recorded at 
306 
room temperature at two fixed wavelengths by 
means of the same spectrophotometer. 
Ethylmorphine was a generous gift from Dr 
M.A. Iorio of the Istituto Superiore di Sanita, 
Laboratory of Pharmaceutical Chemistry (Roma, 
Italy). Hepes and thiobarbituric acid were ob- 
tained from Sigma (St. Louis, MO). SKF 525-A 
was a product of Smith, Kline and French 
Laboratories (Philadelphia, PA). 3-Methylcholan- 
threne was purchased from Eastman Kodak Com- 
pany (Rochester, NY). Sodium phenobarbital was 
obtained from BDH (Poole, England). All other 
chemicals were products of E. Merck (Darmstadt) 
of reagent grade quality. 
3. RESULTS 
Fig. 1 shows the carbon monoxide difference ab- 
sorption spectra of anaerobic rat liver (A) and 
Morris hepatoma 9618A (a) microsomes, together 
with the spectral changes induced by addition of an 
excess of SKF 525-A to aerobic suspensions of the 
corresponding membranes (B and b). Both the CO 
spectra have a peak at 450 nm, indicative of 
cytochrome P-450. The interaction of SKF 525-A 
ly 
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Fig. 1. Room temperature difference absorption spectra 
of cytochrome P-450 recorded in the presence of CO 
(-) and SKF 525-A (---) in rat liver (A, B) and 
hepatoma 9618A (a, b) microsomal suspensions. The 
proteins (2 mg/ml) were suspended in 0.15 M KCl, 
50 mM Tris-HCl (pH 7.5). CO was added to 
NazSzO4-reduced microsomes and SKF 525-A (100 ,uM) 
to aerobic microsomes. 
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Cytochrome P-450 absorbance changes induced by SKF 525-A and carbon 
monoxide in rat liver and hepatoma 9618A microsomes 
Microsomes AA (420-500 nm) AA (450-490 nm) AA (420-500 nm) 
SKF-complex CO-complex AA (450-490 nm) 
Rat liver 0.013 f 0.001 (5) 0.063 f 0.003 (5) 0.204 f 0.013 (5) 
Hepatoma 0.008 + 0.0006 (5) 0.025 f 0.001 (5) 0.305 * 0.015 (5) 
AA values were determined from difference absorption spectra of SKF-treated 
aerobic microsomes and CO-treated anaerobic microsomes, similar to those shown 
in fig. 1, and are expressed for a microsomal protein content of 1 mg/ml. Values 
are means k SE (number of observations) 
with the oxidized hemoprotein causes the ap- 
pearance of characteristic spectra, termed type I 
[14], similar in control and tumor microsomes, 
with an absorption maximum at 385 nm and a 
trough at 422 nm. It can be seen that the amount 
of cytochrome P-450 is considerably lower (about 
2.5fold) in hepatoma microsomes, whereas the 
difference in the magnitude of the SKF 525-A- 
induced spectral change between the two types of 
membrane appears to be less pronounced. This ap- 
pears more clearly from the mean values of the ab- 
sorbance changes of the type I compound and of 
the CO-complex of the reduced pigment, reported 
in table 1, the ratio between such values being 
higher in the hepatoma. 
Fig.2 illustrates the double reciprocal plots of 
changes in absorbance at 422 relative to 450 nm 
caused by consecutive additions of SKF 525-A to 
aerobic suspensions of rat liver and hepatoma 
microsomes. Extrapolation of the plots to the 
abscissa allows one to calculate the concentration 
of the inhibitor needed to obtain the half-maximal 
spectral change, a constant which has been termed 
the ‘spectral dissociation constant’ [14]. Such a 
concentration does not differ significantly in the 
two microsome types (rat liver, 2.2 pM; hepatoma, 
2.4 pM). 
The above data indicate that the tumor P-450 
hemoprotein, although being diminished, may be 
interacting with SKF 525-A in a manner similar to 
that of liver. Information about the extent to 
which cytochrome P-450 is implicated in the 
hepatoma microsomal lipid peroxidation should 
thus be given by the use of inhibitors, such as SKF 
525-A, and/or substrates of mixed-function ox- 
idase. Fig.3 presents the inhibitory effect obtained 
by such drugs on the t-BuOOH-induced lipid 
peroxidation of control and hepatoma mem- 
branes. The range of concentration employed as 
well as the degree of inhibition (about 60%) were 
comparable in control and tumor membranes for 
SKF 525-A and ethylmorphine. Conversely, pro- 
gesterone was less effective in hepatoma 
microsomes. 
Microsomal monooxygenase activities are in- 
duced in several lines of Morris hepatomas by 
treatment of the tumor-bearing rats with 
phenobarbital (PB) or MC [15-171. Induction of 
such activities is parallel to the increase in cyto- 
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Fig.2. Double reciprocal plots of changes in absorbance 
following the addition of increasing concentrations of 
SKF 525-A to aerobic rat liver (0) and hepatoma %18A 
(0) microsomes. The measurements were performed in 
a dual-wavelength spectrophotometer at 422-450 nm, 
using 2 mg microsomal proteins per ml of the KCl/Tris- 
HCl medium. Each point is the mean of 5-10 
determinations. 
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Fig.3. The effect of various drugs on t-BuOOH-dependent lipid peroxidation of rat liver (0) and hepatoma 9618A (0) 
microsomes. The experimental conditions were: 0.2 mg protein/ml and 0.25 mM t-BuOOH in the presence of SKF 
525-A; 0.5 mg protein/ml and 2 mM t-BuOOH in the presence of progesterone or ethylmorphine. Incubation time: 
20 min. The 100% values of lipid peroxidation, expressed as nmol MDA/20 min per mg protein, correspond to 7.44 
k 0.54 (9) and 2.42 + 0.26 (13) (SKF 525-A experiment); 12.1 f 0.71 (4) and 3.90 f 0.26 (14) (progesterone xperiment); 
10.20 f 0.29 (8) and 4.70 f 0.05 (4) (ethylmorphine xperiment), for rat liver and hepatoma microsomes, respectively. 
chrome P-450 content. Phenobarbital administra- 
tion to Buffalo rats bearing the hepatoma 9618A 
did not increase, however, the level of the tumor 
microsomal pigment (not shown). Instead, as 
shown in fig.4, treatment of the rats with MC caus- 
ed the appearance of a cytochrome, with an ab- 
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Fig.4. Difference absorption spectra of hepatoma 9618A 
cytochrome P-450 and P-448. Microsomal membranes 
were isolated from hepatomas of untreated (a) or MC- 
treated (b,c,d) rats. The cytochrome contents were 0.33 
(a), 0.63 (b), 0.78 (c) and 0.93 (d) nmol/mg protein. 
Experimental conditions are described in section 2. 
sorption peak at 448 nm in the CO-reduced form, 
similar to the hepatic species induced by various 
polycyclic hydrocarbons, known as cytochrome 
Pr-450 [ 181 or cytochrome P-448 [ 191. The induced 
levels of the hemoprotein in the hepatoma 
microsomes were not always the same, ranging 
from 0.2 to 0.93 nmol/mg protein (see figs 4 and 
5). This allowed us to establish a relationship be- 
tween the cytochrome content and the extent of 
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Fig.5. Relationship between cytochrome P-450 or P-448 
content and tBuOOH-induced lipid peroxidation in 
microsomes isolated from rat liver (0) and hepatomas 
9618A of untreated (0) or MC-treated (A) rats. The 
peroxidation reaction mixture contained 0.2 mg 
protein/ml and 0.25 mM t-BuOOH. P-450 and MDA 
values are means f SE of 7 experiments for rat liver and 
4 experiments for hepatoma 9618A of untreated rats. 
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malondialdehyde production in a t-BuOOH- 
induced peroxidative system (fig.5). It appears 
clearly that hepatoma microsomes with increasing 
cytochrome levels catalyze proportionally higher 
rates of lipid peroxidation. 
4. DISCUSSION 
Microsomes isolated from slow-growing 
hepatomas, although they are able to catalyze 
reasonable rates of lipid peroxidation, appear to be 
less susceptible to this process, when compared to 
normal liver microsomes [l]. Such resistance, 
which is more evident in the ROOH- or in the 
NADPH-dependent systems, has been ascribed to 
deficiency of cytochrome P-450 [3,7]. Indeed, 
microsomes from Morris hepatoma 9618A, which 
is a slow-growing, highly differentiated carcinoma, 
lack about 60% of the liver cytochrome P-450. 
That the amount of the hemoprotein still present 
participates to a great extent in the t-BuOOH- 
dependent peroxidative activity of these micro- 
somes, by functioning as a ROOH and LOOH ox- 
idase, is suggested by the marked inhibitory effect 
elicited by aminopyrine, a drug hydroxylation 
substrate [3]. In the present work confirmatory 
evidence for the involvement of cytochrome P-450 
in the hepatoma 9618A microsomal ipid peroxida- 
tion was obtained by the experiments performed 
with the inhibitor SKF 525-A and two mixed- 
function oxidase substrates, progesterone and 
ethylmorphine. SKF 525-A has a binding affinity 
for cytochrome P-450 similar in hepatoma and 
liver microsomes, as indicated by spectral titration 
experiments. However, comparison of the mag- 
nitude of the spectral changes observed in the 
presence of CO and SKF 525-A in the two 
microsomal systems reveals that in hepatoma 
membranes the maximal binding capacity of the 
P-450 hemoprotein is proportionally lower for CO 
than for SKF 525-A. t-BuOOH-dependent lipid 
peroxidation of control and tumor membranes is 
inhibited to the same extent (about 60%) in the 
presence of either SKF 525-A or ethylmorphine; 
conversely, progesterone is less efficient in the 
hepatoma (30% vs 50% inhibition). As already 
suggested for the effect observed in the presence of 
aminopyrine [3], progesterone and ethylmorphine 
would inhibit lipid peroxidation by competing for 
t-BuOOH. Indeed, these drugs are capable of 
reducing hydroperoxides to the corresponding 
alcohols, in a cytochrome P-450-catalyzed reac- 
tion, via a peroxidase-type mechanism [4,20-221. 
Among them only progesterone seems to interact 
differently with the hemoprotein in the two 
microsome types, a result which, combined with 
that of the decreased CO binding capacity of the 
hepatoma pigment, might suggest he existence in 
the tumor membranes of cytochrome P-450 isoen- 
zymes with somewhat altered functional prop- 
erties. 
If cytochrome P-450 is implicated in the ROOH- 
dependent hepatoma microsomal lipid peroxida- 
tion, by reacting with ROOH and LOOH to yield 
initiating and propagating radicals, respectively, 
but its low availability is the rate-limiting step in 
the process, restoration of normal hemoprotein 
levels should remove the resistance to ROOH. This 
was obtained by treatment of the tumor-bearing 
rats with 3-methylcholanthrene which induced the 
appearance of amounts of cytochrome P-448 com- 
parable to those of liver cytochrome P-450. These 
results strongly support our hypothesis that 
cytochrome P-450 deficiency limits the lipid perox- 
idation of slow-growing hepatoma microsomes 
and also indicate that other forms of the hemopro- 
tein, such as cytochrome P-448, may participate in 
microsomal peroxidation. 
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